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Research Article
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Introduction
In the past decade, the prevalence of obesity and Type 2 Diabetes 
Mellitus (T2D) is increasing worldwide particularly in the developing 
countries undergoing economic transition to a market economy such 
as China. A 1% increase in the prevalence of obesity in the country 
leads to 20 million additional obese cases. The increase in obesity has 
an important impact on the global incidence of T2D, cardiovascular 
disease, cancer and other diseases [1-4]. Therefore, identification of the 
genes and gene variations that regulate Body Mass Index (BMI) will 
help us to understand the underlying mechanisms of the diseases and 
possibly aid in the development of novel prevention and therapeutic 
approaches. 
RGS9 protein is a member of the family of Regulators of G-Protein 
Signaling (RGS) proteins and expression of RGS9 is highly enriched 
in the striatum region of the brain [5-9]. Dopaminergic circuits in the 
striatum are activated by stimuli associated with reward and are also 
densely interconnected with the hypothalamus, a brain region that 
is critical for regulating energy expenditure [10]. These dopamine-
sensitive striatal reward centers have been shown to be involved 
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Abstract
Objective: RGS9 is a member of the family of Regulators of G-Protein Signaling (RGS) proteins defined by the 
presence of an RGS domain which can accelerate the GTPase-activity of G protein Gα subunits. An insertion/deletion 
(I/D) polymorphism of the nucleotide sequence TTTCT (rs3215227) has been identified in the human RGS9 gene, 
which matches the consensus high affinity binding motif for the ubiquitously expressed RNA binding Polypyrimidine 
Tract Binding Protein (PTB). In this study, we evaluate the genetic association and functional relevance of this 
polymorphism in type 2 diabetes and obesity.
Subjects and methods: We genotyped a larger population of 9272 Chinese and Malaysian individuals for 
the RGS9 I/D polymorphism using TaqMan allelic discrimination protocols. We found that the D allele of the RGS9 
polymorphism was associated with a decreased prevalence of obesity in women (P=0.003, OR=0.753 95%CI 
0.625-0.906) and girls (P=0.002, OR=0.604 95%CI 0.437-0.835). The association was moderate in boys (P=0.038, 
OR=0.724 95%CI 0.533-0.983) and not significant in men. Furthermore, we found that the transcript deletion variant 
exhibited a 10-fold reduction in PTB binding in vitro and that the splicing of the deletion variant was less affected by 
PTB co-expression. 
Conclusions: We provide genetic and biochemical data to support a genetic role of RGS9 in obesity but unlikely 
in T2D. The RGS9 I/D polymorphism influence the post-transcriptional processing of the gene through an altered 
affinity for the splicing factor PTB and are associated with obesity. 
in obesity which could be produced either by heightening reward 
responses to food or by suppressing energy expenditure [10-12]. 
An Insertion/Deletion (I/D) polymorphism of the nucleotide 
sequence TTTCT (rs3215227 in dbSNP) [13] has been identified 
in intron 13 of the human RGS9 gene, which precisely matches the 
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consensus high affinity binding motif for the ubiquitously expressed 
RNA binding Polypyrimidine Tract Binding Protein (PTB) [14]. PTB 
and its neuronally expressed paralog nPTB [15] are the dominant 
splicing repressor in humans and have been shown to regulate many 
alternative splicing events. PTB and nPTB have indistinguishable 
binding specificities and a near complete overlap of functional targets 
[15]. PTB has also been implicated in polyadenylation, message 
stabilization, translation from internal ribosome entry sites and as 
a RNA chaperone [16]. The location of the RGS9 I/D polymorphism 
[8] and coincidence with a PTB binding motif [14] suggested that the 
presence of the deletion could alter processing of the RGS9 transcripts 
and have important functional consequences: exons 13 and 14, that 
flank the TTTCT I/D polymorphism, code for the conserved RGS 
domain that mediates GTPase accelerating protein (GAP) function 
[8,17]. Hence, incorrect splicing of these exons will result in protein 
products that lack a functional RGS domain. 
In a previous study, we demonstrated that rgs9 knockout mice 
became obese and had increased adiposity compared to their wild-type 
littermates [18]. Conversely, the virally transduced overexpression, 
specifically of rgs9 proteins (and not other R7 RGS proteins) in the 
nucleus accumbens (NAc) of rats produced a reduction in body weight 
[18]. In that study, we also investigated if there was an association 
between the RGS9 I/D polymorphism and BMI [18]. Since the micro-
deletion allele is rare in European Caucasians [13], we had genotyped 
for the RGS9 I/D polymorphism in a limited number samples from 
491 Asian individuals that was available to us [18] and found that the 
mean BMI of individuals carrying with the D allele was significantly 
higher than those that tested negative for the deletion. However, the 
generalizability of those results was limited by 1) the limited sample 
size, 2) the heterogeneous ethnic composition of the cohort which 
included individuals who identified themselves as either Chinese, 
Japanese, Korean, Pacific Islander, or Southeast Asian and 3) the 
significant variation in the frequency of the D and I alleles between the 
different ethnic groups.
To address these concerns, in this study, we asked if the I/D 
polymorphism was associated with obesity in a larger sample of 
2737 Chinese adults and 816 children. We also investigated whether 
the polymorphism was associated with T2D in a sample of 6535 
Chinese and Malaysian. Furthermore, we have expanded on those 
results by demonstrating allelic differences in the binding of PTB to 
the RGS9 transcript and present data from minigene experiments that 
demonstrated allelic, PTB-dependent, effects on the splicing of RGS9 
transcripts in vivo. 
Materials and Methods
Subjects
In the present study, a total of 9272 subjects in Chinese and 
Malaysian populations were selected for genetic association study. 
Clinical characteristics of the subjects are represented in Table 1. 
Collection of the subjects in each cohort is described briefly as below.
First cohort: Lean and obese Chinese adults: A total of 4138 
subjects were recruited in Jiangsu province, China, from a population 
of 16,034 by epidemiological stratification sampling with ages ranging 
from 35 to 85 years. According to the criteria of overweight/obesity for 
Chinese from working group on obesity in China (WGOC) [19], 820 
(females 541/ males 279) subjects with BMI>28 kg/m2 were defined as 
having an obese phenotype and 1,100 (females 687/males 413) subjects 
with BMI ranging from 18.5-23.9 kg/m2 were defined as having a lean 
phenotype.
Second cohort: Chinese children with and without over-weight: 
Chinese children aged 5-15 years were selected from primary and 
middle schools located in Jiangsu province, China. The children and 
their parents provided informed consent and completed a questionnaire 
to provide information covering age, gender and education. Within this 
population (n=2,373), 361 (157/204) children were overweight, i.e. had 
a BMI that exceeded the 80th percentile for their age (P80) and 451 
(215/236) children had BMIs that ranged from 20th to 50th percentile 
(P20-50) for their age. 
Third and fourth cohorts: Chinese adults with and without type 
2 diabetes (T2D): Chinese adults with and without T2D were selected 
respectively from the regions of Jiangsu province and Beijing city in 
China. All patients with T2D were diagnosed according to the World 
Health Organization (WHO) criteria, 1998 [20]. 1279 patients with 
T2D and 1990 subjects with normal fasting plasma glucose levels were 
included in the present study from Jiangsu province. 1049 (496/553) 
patients with T2D and 1004 (520/484) non-diabetic subjects were 
enrolled as previously described from regions around Beijing. Subjects 
with BMI>28.0 kg/m2 were excluded from the study [21]. 
Fifth cohort: Adults with and without T2D from Malaysia: 
Malaysians subjects including 575 (268/307) non-diabetic controls and 
643 (311/332) T2D patients were collected from the university hospitals 
in the states of Kelantan, Putrajaya and Penang, Malaysia. The ethnic 
break-up of the Malaysian population was as follows: 64.6% Malay, 
17.5% Chinese, 15.5% Indians and 2.4% indigenous. Subjects with 
BMI>28.0 kg/m2 were excluded from the study. 
Sample Origin Region/Country Group N (Female%) Age (years) BMI (kg/m2) FPG (mmol/l)
Sample 1 Chinese Jiangsu, China
Adults with lean 1100 (62.5) 59.4  ±  10.7 21.5 ± 1.5 5.1 ± 0.8
Adults with obese 820 (66.0) 59.9  ±  10.4 29.1 ± 2.0* 6.0 ± 2.2*
Sample 2 Chinese Jiangsu, China
Children without overweight 451 (43.6) 10.1  ±  2.9 16.4 ± 1.5 4.2 ± 1.0
Children with overweight 361 (47.3) 10.1  ±  3.0 21.3 ± 3.8* 4.3 ± 1.0
Sample 3 Chinese Jiangsu, China
Non-diabetic controls 1990 (63.5) 60.1 ± 10.3 22.5 ± 2.9 4.4 ± 0.4
Type 2 diabetes 1279 (65.3) 60.2 ± 9.5 25.4 ± 3.7* 8.7 ± 3.3*
Sample 4 Chinese Beijing, China
Non-diabetic controls 1004 (51.7) 55.6 ± 9.6 25.3 ± 3.6 5.0 ± 0.3
Type 2 diabetes 1049 (47.3) 55.8 ± 10.1 25.3 ± 3.4 9.0 ± 3.1*
Sample 5 Malaysian  Penisular, Malaysia 
Non-diabetic controls 575 (49.6) 45.8 ± 15.1 26.0 ± 5.1 5.6 ± 0.7
Type 2 diabetes 643 (51.7) 56.3 ± 10.4 27.8 ± 5.2 8.6 ± 3.1*
Total 9272 (57.1)
Data are means ± SD. BMI: body mass index. FPG: fasting plasma glucose. *P<0.05 for comparing with controls.
Table 1: Clinical characteristics of subjects.
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by Wang and colleagues [22]. The small constitutively spliced central 
exon of the original splicing reporter contains two restriction cloning 
sites, Xho1 and Apa1, into which we inserted a synthesized (Epoch Life 
Sciences, Missouri City, TX) fragment of the human RGS9 gene [18]. 
The inserted RGS9 gene fragment consisted of the final 57 base pairs 
of exon 13 (Supplement Figure S1A, grey box,) followed by a fusion 
of the first 100 and the last 243 base pairs in the adjacent intron 13 
(Supplement Figure S1A, dashed grey bar). The insertion of the regions 
from intron 13 of the RGS9 gene effectively splits the central exon 
of the original minigene into 2 separate exons thus creating a new 
minigene construct with 4 exons (Figure S1A). Two splicing reporters 
were constructed, one in which the inserted RGS9 gene fragment was 
synthesized with TTTCT insertion (I) and another one in which the 
inserted RGS9 gene fragment was synthesized with TTTCT deletion 
(D) at the appropriate intron 13 site. 
Human embryonic kidney cells (HEK293, American Type Culture 
Collection, and Manassas, VA) were separately co-transfected with a 
splicing reporter minigene constructs containing either the RGS9 
TTTCT I or D allele’s deletion positive and cDNA encoding for either 
PTB or nPTB. The transient transfections were performed using 
LTX transfection reagent (according to manufacturer’s instructions 
Invitrogen, Carlsbad, CA). After 48 hr the cells were harvested and 
total cellular RNA was isolated using TRIzol reagent (according to 
manufacturer’s instructions, Invitrogen). Next, the RNA was reverse 
transcribed (reverse transcriptase enzyme, Sigma Aldrich) at 37˚C for 
50 min in a reaction that was primed with random hexamer nucleotides 
and contained dNTP mixture and RNase inhibitor (Ambion) and buffer 
provided by the enzyme supplier. 
Identification of RNA binding proteins by UV-cross linking
All templates for transcription were ordered as custom DNA 
oligonucleotides containing T7 promoters from IDT (idtdna.com). An 
oligo complimentary to the T7 promoter was also purchased, and the 
two were mixed in equimolar ratios, heated to 95˚C and allowed to cool 
slowly at room temperature. These mixtures served as transcription 
templates for a T7 polymerase reaction using the MEGA short script 
Written informed consent was obtained for each subject. Written 
informed consent was obtained from the subject or from the parents or 
guardians if the subjects were children or minors. The sample and data 
collection procedures were approved by the local ethics committees, 
respectively. The full names of the respective ethics committee/
institutional review boards are as follows: the Research Ethics Committee 
of Nanjing Medical University, Nanjing, China (IRB NMU-1-1-2011), 
the Ethics Committee of the Institute of Basic Medical Sciences, Chinese 
Academy of Medical Sciences, Beijing, China (PUMC-019-2011), 
and the Medical and Research Ethics Committee, Ministry of Health 
Malaysia, Kuala Lumpur, Malaysia (IMR-3-3-2007). All these studies 
were carried out in accordance with the declaration of Helsinki II. 
Genotyping
The ID number of the RGS9 I/D polymorphism in dbSNP 
is rs3215227. The position of this RGS9 I/D polymorphism is 
represented in Figure 1. To genotype the RGS9 I/D polymorphism 
with TaqMan allelic discrimination, a SNP genotyping assay (ID: 
AH0I2R) was designed and then synthesized by Life Technologies 
(Grand Island, USA). In addition, a specific PCR protocol was 
also designed for genotyping the polymorphism. The primers 
included RGS9delF1 (5’-aaagaggaaataaatgagtcaa-3’), RGS9delF2 
(5’-agttggaagaagaaaagaggaaataaaagaaa-3’) and RGS9delR 
(5’-agttggaagaagaaaagaggaaattaa-3’). The PCR program was 95˚C, 
5min; (95˚C, 30sec; 54˚C, 30se; 72˚C,30 sec) x 31; 72˚C, 8 min. PCR 
fragments of sizes 104 bp (deletion allele) and 122 bp (insertion allele) 
were detected with 3% w/v agarose gels and gel electrophoresis. 
Splicing reporter mini-gene assay 
The reporter system and assay used to screen for the possible 
actions of PTB binding on the splicing of gene segments containing 
the RGS9 I/D polymorphism has been previously described and a 
schematic of the minigene construct is shown in this Supplement 
section, Figure S1A [18]. The splicing reporter was derived from a 
plasmid vector containing a 3 exon minigene under the control of the 
human cytomegalovirus promoter that has previously been described 
Figure 1: rs3215227 encodes a micro deletion in the 3’ splice site (3’ss) region of RGS9 intron 13.  
RGS9 gene architecture, annotated with mammalian conservation scores and splicing cis-elements (i.e. branch point, polypyrimidine tract, 3’ splice site (3’ss), shaded 
tan) are displayed.  The five nucleotide microdeletion located 72 nucleotides upstream of the 3’ss encompassing a predicted binding site for the splicing repressor 
PTB is shaded blue.  Additional predicted PTB binding sites are underlined in blue.  The regions used to design RNA probes for in vitro binding assay are indicated 
below the gene sequences.  
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transcription kit (Ambion). Unlabeled cold competitors were prepared 
following the protocol supplied with the kit, whereas radiolabeled 
probe for UV-crosslinking experiments was prepared with the addition 
of 32P UTP to a final concentration of 10 µCi. All samples were purified 
using the phenol-chloroform extraction and ethanol precipitation 
method and visualized on 7 M urea polyacrylamide gels and quantified 
via phosphor imaging (Image Quant; GE Healthcare) and/or UV 
spectrometry (Nanodrop).
For each reaction, the radiolabeled probe (wt/R9 RNA and D/R9 
RNA in 1, 5 or 10 molar excess for either of the RNA probe) was added 
to 30 µg of HeLa cell nuclear extract. Volume was raised to 80 µL with 
Buffer E (20 mM Tris pH 7.9, 0.1 M KCl, 0.2 mM EDTA, 20% glycerol, 
0.5 mM DTT) and incubated at 25˚C for 30 min. Reactions were 
exposed to UV in a UV-crosslinker FB-UVXL-1000 (Fisher Scientific) 
for 15 min at 120 mJ/cm2, 5 cm from the UV source. RNA was digested 
using RNAse A/T1 mix (Ambion) for 1 hr at 37˚C. For competition 
assay, 200 ng (0.01 nM) of radiolabeled probe (S11) were added to 30 µg 
of HeLa cell nuclear extract with an increasing amount (0, 5, or 50 fold 
molar excess) of unlabeled competitor RNA. The rest of the protocol is 
same as described above for UV cross linking experiment. All samples 
were then separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS PAGE), dried at 80˚C for 25 min, and imaged 
using a GE Healthcare storage phosphor screen and scanned on a 
Typhoon 9410 variable mode imager and packaged software.
Statistical analyses
The power of the genetic association study (cases and controls) 
was calculated with the software of Power and Sample Size Calculation 
(Dupont WD, Plummer WD: http://biostat.mc.vanderbilt.edu/ twiki/
bin/view/Main/Power Sample Size). At the 5% significance levels, we 
had 82% power to detect OR of 0.8 or 1.25 with a MAF D allele of 0.25 
in adult obesity population for generating the association hypothesis of 
RGS9 I/D polymorphism and obesity in this study. For the association 
analysis of RGS9 I/D polymorphism and T2D, the Jiangsu population 
has over 90% power to detect OR of 0.8 or 1.2 with a MAF D allele of 
0.28 in control population. 
Among controls, genotype frequencies were analyzed by Fisher’s 
exact test for Hardy-Weinberg equilibrium (HWE). The allele 
frequencies and genotype distributions between cases and controls 
were compared by the Chi-square (χ2) test and a P-value of 0.05 was 
defined to be statistically significant. Odds Ratios (OR) and 95% 
Confidence Intervals (CI) were calculated to test for association. For 
the stratification analysis, a multiple unconditional logistic regression 
was applied to evaluate the association. The adjustment for covariates 
including age and sex was done in the analyses of allelic association 
with obesity, while the adjustment for age and BMI was used in the 
analyses of the association with T2D in males and females, respectively. 
All analyses were performed using IBM SPSS Statistics (Version 20, 
SPSS Inc, and Chicago, USA). 
In addition, a mata-analysis was used to systematically evaluate 
the association of RGS9 I/D polymorphism and T2D for Chinese 
Jiangsu population, Beijing population and Malaysia population. 
Heterogeneity chi-squared test was used to detect the variation in 
estimation attributable to heterogeneity and if I-squared is less 50.0%, 
random model would be selected to calculate the pooled OR of the 
association between RGS9 I/D polymorphism and T2D. The analyses 
were performed using Stata 10.0 (StataCorp LP, College Station, TX). 
Results
The RGS9 gene in human consists of 19 exons and the RGS9 I/D 
(TTTCT insertion/deletion) polymorphism (rs3215227 in dbSNP) is 
located in intron 13. Comparison with other primate species suggests 
that the polymorphism arose in the human lineage as a TTTCT deletion 
at some point after the human-chimpanzee divergence (Figure 1). 
We performed a genetic association study of the RGS9 I/D 
polymorphism with obesity and T2D in a larger sample set of Chinese 
and Malaysian subjects. The D allele frequency was present at 23.8% 
and 28.5%, respectively, in these two Asian populations. The genotype 
distributions of the RGS9 I/D polymorphism in the studied populations 
were kept in HWE and the results of the study are summarized in Table 
2. The genotype distributions of the RGS9 I/D polymorphism in the 
studied populations were kept in Hardy-Weinberg equilibrium. In 
the Chinese population, women who were obese (BMI ≥ 28) had a 
significantly (P=0.003, OR=0.757, 95% CI 0.631-0.909) lower frequency 
(23.7 vs 29.0%) of the D allele compared to the women who were lean 
(BMI 18.5-23.). The D allele frequency was not different between lean 
and obese Chinese men (26.2% vs. 26.6%, P=0.877). In Chinese children, 
the D allele was found to be strongly associated with a decreased risk 
for obesity in girls (25.5% vs. 36.3%, P=0.002, OR=0.600, 95% CI 0.436-
0.828) and moderately associated with a decreased risk for obesity in 
boys (24.3% vs. 30.5%, P=0.039, OR=0.730, 95% CI 0.541-0.984).
Further stratification analyses for the association of the RGS9 I/D 
polymorphism with obesity were performed separately in women and 
men and also adjusted for covariates including age, BMI, daily diet and 
levels of physical activities. Results of the study are summarized in Table 
3. In the Chinese population, women who were obese had a significantly 
(23.7 vs 29.0%, P=0.003, OR=0.753, 95% CI 0.625-0.906) lower frequency 
Region/Country
Population Group
Genotype Allele D
Frequency
P-value 
OR (95% CI) aI/I I/D D/D
Jiangsu/China
Chinese
Adults, lean BMI 18.5-23.9 566 452 82 0.28 0.019a
0.838 (0.723-0.972) aAdults, obese BMI ≥ 28 463 310 47 0.25
Jiangsu/China
Chinese
Children BMI p20-50 204 194 53 0.33 3.1×10-4 a
0.667 (0.535-0.831) aChildren BMI p>80 202 139 20 0.25
Jiangsu/China
Chinese
Non-diabetic 1035 814 141 0.28 0.820b
1.014 (0.870-1.147) bT2DM 678 509 92 0.27
Beijing/China
Chinese
Non-diabetic 537 372 95 0.28 0.999b
1.000 (0.876-1.141) bT2DM 555 397 97 0.28
Penisular/Malaysia
Malaysian
Non-diabetic 331 241 57 0.28 0.741b
0.966 (0.785-1.188) bT2DM 295 239 50 0.29
Tests were done with an additive model; BMI: Body Mass Index; T2DM: Type 2 Diabetes; a: Adjustment for Age and Sex; b: Adjustment for Age, Sex and BMI.
Table 2: The allele D frequency of the RGS9 I/D polymorphism and its association with obesity.
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of the D allele compared to the women who were lean (23.7 vs. 29.0%, 
P=0.003, OR=0.753, 95% CI 0.625-0.906). The D allele frequency was 
not different between lean and obese Chinese men (26.2% vs. 26.6%, 
P=0.965, OR=1.006, 95% CI 0.782-1.293). In Chinese children, the D 
allele was found to be strongly associated with a decreased risk for obesity 
in girls (25.5% vs. 36.3%, P=0.002, OR=0.604, 95% CI 0.437-0.835) and 
moderately associated with a decreased risk for obesity in boys (24.3% vs. 
30.5%, P=0.038, OR=0.724, 95% CI 0.53-0.983). 
In order to ask if there was any association between the RGS9 I/D 
polymorphism and T2D, we selected two cohorts of Chinese (from 
Jiangsu province and Beijing, respectively) and one cohort of Malaysian 
adults with and without T2D for analyses and those patients were not 
obese. We found no significant difference in the D allele frequency 
between non-diabetic controls and T2D patients in either the Chinese 
or Malaysian populations (Table 2) although the analyses were 
stratified by gender (Table 3). In addition, a mata-analysis was used to 
systematically evaluate the association of RGS9 I/D polymorphism and 
T2D for Chinese Jiangsu population, Beijing population and Malaysia 
population. Heterogeneity test indicated that there is no heterogeneity 
among the study populations (χ2=0.15, P=0.930) and I2 was 0.0%, 
random model was selected to calculate the association and pooled OR 
(95%CI) was 1.000 (0.917-1.090) for the association between RGS9 I/D 
polymorphism and T2D (z=0.00, P=0.997).
Since the RGS9 I/D polymorphism was strongly associated 
with obesity and matched the consensus binding motif for the RNA 
binding Polypyrimidine Tract Binding Protein (PTB) [23], we tested 
if the polymorphism could modulate RGS9 gene function through a 
mechanism of allele specific interactions with PTB. In our previous 
study, we had shown that processing of the RGS9 gene transcript 
was altered by the I/D polymorphism, but we did not report on the 
binding of PTB to the RNA alleles or the effect of PTB expression 
transcriptional processing of these RNA alleles. Exons 13 and 14, which 
flank the polymorphism, code for the conserved and functionally 
important RGS domain. Therefore, alterations in splicing, such as exon 
skipping, at this site, produced as a result of reduced PTB binding to the 
D allele, will lead to alterations in the levels of functional RGS9 protein. 
Altered PTB binding could also result in allele specific changes in RNA 
polyadenylation, stability or structure [23]. 
We assayed the RGS9 I/D RNA alleles for differences in binding 
to PTB in cell nuclear extracts. The binding affinity of PTB to these 
allelic RNA substrates was determined using a standard Ultraviolet 
(UV) cross-linking reaction. Briefly, this assay captures RNA-protein 
binding events through a label transfer strategy. RNA corresponding 
to the 2 alleles is transcribed utilizing 32P-radio-labeled nucleotides 
and incubated with a nuclear extract from cells to allow RNA-protein 
complexes to form. The internally radio-labeled RNA is covalently 
cross-linked to bound protein using UV light. RNAses are used to “trim” 
the RNA that is covalently attached to protein to a few nucleotides and 
the trimmed RNA effectively serves as a radiolabel for the interacting 
proteins. The mobility of these labeled RNA-binding proteins can be 
measured by Poly-Acrylamide Gel Electrophoresis (PAGE) and their 
identity confirmed by immunoprecipitation. 
Region/Country
Population Gender Group
Genotype Allele D
Frequency
P-value 
OR (95% CI)I/I I/D D/D
Jiangsu/China
Chinese Women
Adults, lean BMI 18.5-23.9
Adults, obese BMI ≥ 28
342
316
291
194
54
31
0.290
0.237
0.003a
0.753 (0.625-0.906) a
Jiangsu/China
Chinese Men
Adults, lean BMI 18.5-23.9
Adults, obese BMI ≥ 28 
224
147
162
116
27
16
0.262
0.265
0.965a
1.006 (0.782-1.293) a
Jiangsu/China
Chinese Girls
Children BMI p20-50
Children BMI p>80
91
85
92
64
32
8
0.363
0.255
0.002a
0.604 (0.437-0.835) a
Jiangsu/China
Chinese Boys
Children BMI p20-50
Children BMI p>80
113
117
102
75
21
12
0.305
0.243
0.038a
0.724 (0.533-0.983)a
Jiangsu/China
Chinese Women
Non-diabetic BMI<28
T2DM BMI<28
656
450
511
325
97
60
0.286
0.266
0.669b
0.967 (831-1.126)b
Jiangsu/China
Chinese Men
Non-diabetic BMI<28 
T2DM BMI<28
379
228
303
184
44
32
0.269
0.279
0.317b
1.113 (0.902-1.372)b
Beijing/China
Chinese Women
Non-diabetic BMI<28
T2DM BMI<28
281
263
193
197
46
36
0.274
0.271
0.815b
0.977 (0.805-1.186)b
Beijing/China
Chinese Men
Non-diabetic BMI<28
T2DM BMI<28
256
292
179
200
49
61
0.286
0.291
0.833b
1.020 (0.850-1.223)b
Penisular Malaysia
Malaysian Women
Non-diabetic  BMI<28 
T2DM BMI<28
142
158
102
126
24
27
0.280
0.289
0.168b
0.809 (0.599-1.094)b
Penisular Malaysia
Malaysian Men
Non-diabetic BMI<28
T2DM BMI<28
158
172
120
133
29
27
0.290
0.282
0.395b
1.135 (0.848-1.517)b
Tests were done with an additive model; BMI: Body Mass Index; T2D: Type 2 Diabetes; a: Adjustment for Age; b: Adjustment for Age and BMI
Table 3: Stratification analysis on the association of RGS9 I/D polymorphism with obesity.
A
TTTCT TTTCT
I D
TTTCT TTTCT
I D
150-
100-
75-
50-
37-
150
100
75
50
37
150-
100-
75-
50-
37-
1 2 3  4 5  6  7  8  9
S11
S11
cold
comp
probeIP
UV
-  +
B
-    -   5x 50x -   5x 50x
+   +    +   +   +   +   +
-    +   +   +   +    +   +
Figure 2: PTB binds the RGS9 TTTCT insertion (I) allele with 10-fold higher 
affinity than the deletion (D) allele.  
RNA oligos corresponding to the I and D alleles and the previously 
characterized PTB ligand, S11, were radiolabelled, incubated in HeLa extract 
and UV crosslinked to interacting proteins.  Radiolabeled crosslinked proteins 
were visualized by SDS-PAGE/autoradiography.  A.  A prominent 58 kD band 
corresponding to the molecular weight of PTB can be detected on both the I 
and D allelic probes.  B.  The 58 kD band is also detected with the S11 ligand 
(lane 1) and can be immunoprecipitated with antibodies against PTB (lane 2). 
The relative strength of the I or D RNA allele to bind PTB is inferred from the 
ability of unlabeled RNA probes (cold comp), corresponding to these alleles, to 
compete with the radiolabeled S11 ligand for PTB binding (lanes 3-9).  
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Both the I and D RNA alleles bound a 58 kD protein, that 
corresponded to the molecular weight of PTB, with the I RNA allele 
appearing to bind more strongly (Figure 2A). The same 58 kD protein 
was also detected using a previously characterized RNA ligand for PTB, 
S11 (Figure 2B, left panel) [5]. Crosslinking of radiolabeled S11 with cell 
nuclear extracts followed by immunoprecipitation of PTB confirmed 
that PTB is the dominant 58 kD binding protein for S11 (Figure 2B, 
right panel, lanes 4 and 7). The crosslinking efficiency and degree of 
radiolabel incorporation can vary from one RNA substrate to another 
so that relative signals obtained for the 58 kD protein in Figure 2A do 
not necessarily represent the relative level of binding of the I and D RNA 
alleles to that protein. Therefore, a more accurate representation of the 
level of binding of the RNA alleles to PTB was achieved by examining 
the ability of each of the unlabeled alleles to compete with the binding 
of PTB to the previously characterized radiolabeled RNA ligand for 
PTB, S11 [14]. We performed competition binding experiments to 
PTB with radiolabeled S11 and progressively higher concentrations 
(5-50 molar excess) of unlabeled I and D variants of the RGS9 RNA, 
respectively (Figure 2B, lanes 3-9). The relative strength of the I or D 
RNA allele to bind PTB was inferred from the ability of unlabeled RNA 
probes, corresponding to these alleles, to compete with the radiolabeled 
S11 ligand for PTB binding. The results show that a 10-fold higher 
concentration of the D variant is required to achieve the same amount 
of competition with S11 at PTB as the I allele (Figure 2B, right panel, 
lanes 3-9) and indicate that the I RNA allele does indeed bind PTB with 
much higher affinity than the D variant. 
We then utilized a splicing reporter assay to examine whether the 
difference in interaction between PTB and the two RNA alleles could 
alter how the alleles were functionally processed in cells. Since RGS9 
Figure 3: Alternative splicing of a minigene reporter construct containing the 
RGS9 TTTCT I/D alleles.
A.  The RGS9 I and D allele fragment-containing minigenes were separately 
co-transfected into cells with or without either PTB (left panel) or nPTB (right 
panel).  The minigene transcripts were visualized by reverse transcription, 
PCR amplification and agarose gel electrophoresis.  The bands “a”, “b”, 
and “c” represent alternatively spliced products of the minigene reporter.  B. 
Densitometric quantification of the relative intensity of band “a”, i.e. full-length 
alternatively spliced product, expressed as percentage of the total intensity 
from “a”, “b”, and “c” with and without co-expression of PTB (left panel) or nPTB 
(right panel) (*p<0.01, t test).  
transcripts are primarily expressed either in the brain or the retina we 
also tested the effects of a neuronal paralog of PTB, nPTB. Supplemental 
Figure S1A represents a schematic of the RGS9 mini-gene construct 
composed of four exons with the I/D polymorphism-containing 
sequence from intron 13 of RGS9 inserted between experimental exons 
2 and 3 which was transfected into cells. 
RNA isolated post-transfection was analyzed by reverse-
transcriptase (RT)-PCR. Correct constitutive splicing of all 4 exons 
corresponded to a 451 nucleotide (nt) product (“a” in Figure 3A and 
Supplemental Figure S1B). Coexpression of PTB or nPTB led to the 
repression of correct splicing and the detection of two additional 
PCR products corresponding to distinct alternatively spliced mRNA 
products. The splicing of experimental exons 1 and 2, but skipping of 
the exon immediately downstream of the polymorphism, exon 3, leads 
to splicing of exon 2 and 4 and results in an ~400 nt band (“b” band). 
Splicing of exon 1 and 4 due to skipping of exons 2 and 3 was also 
detected (“c” band).
The repression of splicing produced by co-expression of either PTB 
or nPTB was biased to the RGS9 TTTCT I allele (Figure 3) and the 
fraction of transcript that included all 4 exons (“a” band) produced 
with the I variant was significantly less than with the D variant, i.e. the 
repressive effect of PTB or nPTB was significantly stronger on the I 
allele. We confirmed preferential PTB binding to the I allele in vivo by 
repeating the UV crosslinking in cell culture and coimmunoprecipitating 
the crosslinked PTB/pre-mRNA complexes (Supplemental Figure S2). 
The latter confirmed that the I allele binds more strongly to PTB in 
vivo and thus has a greater potential to be modulated by PTB than the 
D allele. 
Discussion
Here, we have present genetic and biochemical data to support a 
role for the RGS9 TTTCT I/D polymorphism in affecting obesity in 
humans. These findings appear to parallel those us previously observed 
in rodents where RGS9 expression levels are correlated with adiposity/
body weight [18]. 
Men and women differ in body composition, patterns of weight gain, 
hormone biology, metabolic markers and the manner in which social, 
ethnic and environmental factors contribute to the obesity phenotype 
[24-26]. In this context, our observation of a sexually dimorphic 
association of a polymorphism in the RGS9 gene is significant as it is 
one of few studies that have demonstrated sex-specific effects of weight-
influencing gene variants. Our previous mouse studies had produced 
similar results: targeted disruption of the rgs9 gene resulted in a more 
pronounced increase in body weight in female mice and the divergence 
in body weight between the knockout mice and wild-type mice occurred 
at an earlier age in females [18]. The mechanisms underlying the sex-
specific effects of obesity and eating behavior are not well understood 
and this study establishes RGS9 as one starting point to study some of 
these mechanisms. 
Human genetic studies have linked variations in two other R7 
RGS proteins, RGS6 and RGS7 to obesity [27]. These studies provide a 
precedent for R7 RGS family proteins regulating body-weight through 
their expression in the brain since the protein products of the R7 
RGS gene family have been reliably detected only in the brain or in 
excitable tissue such as retina and heart [5,9]. Further support for a role 
for R7 RGS proteins in regulating body weight and adiposity has been 
provided through studies with Gβ5, a unique G protein β subunit. It 
has been reported that mice with a targeted deletion of one copy of 
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Gβ5, are heavier and have increased adiposity when compared to their 
wild-type counterparts [28]. Gβ5 protects R7 RGS family proteins from 
proteolysis and expression of R7 RGS family proteins, including RGS9, 
is eliminated or hugely reduced in the absence of Gβ5 [5,29]. 
According to the information from dbSNP database and our 
recent study with a smaller set of Asian subjects [25], the RGS9 I/D 
polymorphism is also common in Japanese and Koreans, which 
suggests that the polymorphism may have utility in biomarker panels 
for predicting obesity in Asian populations. It was more practicable to 
investigate the association in this population versus in Caucasians in 
whom the occurrence of the D allele is quite rare. In fact, our previous 
results with rodents indicate that RGS9 contributes to body weight 
set-points in multiple species and therefore is likely to contribute 
to regulating body-weight in humans regardless of ethnicity [25]. 
Furthermore, most of T2D patients included in this study were not 
obese. Inclusion of T2D patients with lean for the study may allow 
ascertaining whether the RGS9 I/D polymorphism are associated with 
T2D or not.
In conclusion, we present genetic and biochemical data to support 
a genetic role of RGS9 in obesity but unlikely in T2D. The RGS9 I/D 
polymorphism influences the post-transcriptional processing of the 
gene through an altered affinity for the splicing factor PTB and are 
associated with obesity. 
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